U.S. Preventive Services Task Force wants to close evidence gaps
This article was originally published in The Gray Sheet
Executive SummaryAgency for Healthcare Research and Quality seeks comments through May 14 on draft methodology for establishing research priorities in the area of clinical preventive services. The effort will support research on topics that have critical evidence gaps and for which the USPSTF has issued a statement of insufficient evidence, AHRQ says. The draft methodology considers prioritizing the so-called "I" statements by research importance and the process for considering research feasibility
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.